Both SGLT2 and SGLT1 are described to be present in the brain, prostate, and pancreatic cancers; SGLT1 are present on top in ovaries and head and neck cancers; while SGLT2 present on top also in lung cancer. This evidence concerns the gene SLC5A2 and pancreatic neoplasm.